<unk>  (trade name Rigvir) is a wild type member of the<unk> virus group of viruses. It was formerly approved as a virotherapy medication by the State Agency of Medicines of the Republic of Latvia (2004–19). In March 2019, the distribution in Latvia was stopped by the State Agency of Medicines, after laboratory tests found that the amount of<unk>  virus was in much smaller amounts than claimed. On May 31, 2019, the State Agency of Medicines suspended the registration licence of<unk> .
ECHO-7
PAMI
CaBIG
RGC100
GRAd-COV2
PIM2
CEPP
VE 